加拿大魁北克未接种疫苗的16至20岁男性中人乳头瘤病毒基因型的患病率
2020至2022年在魁北克招募369名未接种HPV疫苗的16至20岁性活跃男性,自采阴茎拭子检测HPV,HPV总患病率为18.4%(95%CI 14.6%-22.8%),仅2人(0.5%,95%CI 0.1%-1.9%)携带四价HPV疫苗靶向基因型,作者认为这提示魁北克年轻成人中存在强群体免疫。
要点
- 未接种男性HPV总患病率18.4%(95%CI 14.6%-22.8%),四价疫苗靶向基因型仅0.5%。
- 2名携带四价疫苗靶向基因型者均有男性性接触史。
- 年龄、终生性伴侣数多及其他性传播感染史与HPV阳性独立相关。
核心结论
- 未接种疫苗的同龄男性中四价HPV疫苗靶向基因型患病率低于1%,作者认为这提示魁北克年轻成人中存在强群体免疫,评估免疫程序变更时须考虑该发现。
研究设计与样本
- 2020至2022年从魁北克全省学校和线上招募16至20岁性活跃男性,完成在线问卷并自采阴茎表面拭子,用Anyplex II-HPV28 Detection assay检测HPV基因型,接种状态经魁北克疫苗接种登记核实。
- 共369名参与者提供了适合HPV检测的样本。
主要发现
- HPV总患病率为18.4%(95%CI 14.6%-22.8%)。
- 仅2名参与者携带四价HPV疫苗靶向基因型,患病率0.5%(95%CI 0.1%-1.9%),两人均报告与男性有性接触。
- 多变量分析中,年龄、终生性伴侣数较多及其他性传播感染史与至少一种HPV基因型阳性独立相关。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Since 2008, Quebec (Canada) has had a school-based human papillomavirus (HPV) vaccination program achieving >90% coverage (≥ 1 dose) in girls by age 15. In 2018, Quebec was the first jurisdiction to switch to a mixed schedule (nonavalent + bivalent), and as such wanted to evaluate it. However, when devising an evaluation strategy for new vaccine schedules, the presence of herd effect needs to be ascertained. With this in mind, this study aimed to measure HPV prevalence among unvaccinated 16- to 20-year-old sexually active men. METHODS: In 2020-2022, men were recruited from schools and online across the province of Quebec. Participants completed an online questionnaire and provided a self-collected penile swab (surface) for HPV detection and genotyping (Anyplex II-HPV28 Detection assay). Risk factors associated with HPV positivity were assessed. Vaccination status (unvaccinated) was verified through the Quebec Vaccination Registry. RESULTS: Overall, 369 participants provided a sample suitable for HPV testing. HPV prevalence was 18.4% (95% confidence interval [CI], 14.6%-22.8%). Only 2 participants harbored a quadrivalent (4vHPV)-targeted genotype (0.5% [95% CI, .1%-1.9%]), both of whom reported sexual contact with men. In multivariate analysis, age, greater number of lifetime sexual partners, and history of other sexually transmitted infections were independently associated with positivity for at least 1 HPV genotype. CONCLUSIONS: The low 4vHPV-targeted genotype prevalence (<1%) among unvaccinated men of the same age as women vaccinated with 4vHPV suggests a strong herd immunity among young adults in Quebec. Evaluation of schedule changes will have to take this finding into account. Clinical Trials Registration. NCT04297670.
引用
- Wolfe C, Ionescu IG, Mayrand MH, et al. Prevalence of Human Papillomavirus Genotypes in Unvaccinated 16- to 20-Year-Old Men in Quebec, Canada. J Infect Dis. 2025. PMID: 39982898. doi:10.1093/infdis/jiaf094
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。